Literature DB >> 19951050

Solitary juvenile xanthogranuloma of the temporal muscle and bone penetrating the dura mater in a 2-month-old boy.

Erwin M J Cornips1, Kimberly E M Cox, David H K V Creytens, Bernd Granzen, Jacobiene W Weber, Mariel P Ter Laak-Poort.   

Abstract

Juvenile xanthogranuloma (JXG) is a rare histiocytic disorder primarily observed during the first 2 years of life. Most patients present with a solitary cutaneous lesion; however, others present with extracutaneous manifestations or even with systemic involvement. The authors describe a 2-month-old boy in whom was diagnosed a unifocal extracutaneous JXG involving the temporal bone. Unlike 3 other cases of solitary JXGs of the temporal bone in the literature, the present case involved destruction of the dura mater and leptomeningeal enhancement surrounding the entire temporal lobe. The lesion did not regress after an initial biopsy procedure and had to be removed more radically because of progressive mass effect on the brain. The child recently underwent a reconstructive skull procedure and is doing well almost 2 years postoperatively without evidence of disease. This case demonstrates that even in instances of extensive disease a favorable outcome is possible without chemotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19951050     DOI: 10.3171/2009.7.PEDS09230

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  3 in total

1.  Rapid-growing juvenile xanthogranuloma on the scalp in 18-month-old girl.

Authors:  Young Woo Park; Eun Jeong Koh; Ha Young Choi
Journal:  J Korean Neurosurg Soc       Date:  2011-09-30

2.  Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck.

Authors:  D T Ginat; S O Vargas; V M Silvera; M S Volk; B A Degar; C D Robson
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

3.  Solitary juvenile xanthogranuloma of temporal bone: a case report.

Authors:  Shu-Ni Wang; Ji Lu
Journal:  BMC Pediatr       Date:  2022-02-12       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.